Harbour Capital Advisors, LLC Neurocrine Biosciences Inc Transaction History

Harbour Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	SELL	$79.65 - $106.22 $1.03 Million - $1.37 Million	-12,871 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$86.18 - $99.03 $110,741 - $127,253	1,285 Added 11.09%	12,871 $1.23 Million
Q2 2021 Jul 14, 2021	BUY	$89.43 - $102.27 $108,657 - $124,258	1,215 Added 11.72%	11,586 $1.13 Million
Q1 2021 Apr 12, 2021	BUY	$87.57 - $119.4 $908,188 - $1.24 Million	10,371 New	10,371 $1.01 Million
Q4 2020 Jan 12, 2021	SELL	$86.91 - $108.33 $882,657 - $1.1 Million	-10,156 Closed	0 $0
Q3 2020 Oct 09, 2020	BUY	$96.16 - $135.15 $139,432 - $195,967	1,450 Added 16.66%	10,156 $977,000
Q2 2020 Jul 21, 2020	BUY	$85.09 - $130.36 $95,215 - $145,872	1,119 Added 14.75%	8,706 $1.06 Million
Q1 2020 Apr 08, 2020	BUY	$75.11 - $113.76 $346,031 - $524,092	4,607 Added 154.6%	7,587 $657,000
Q4 2019 Jan 22, 2020	BUY	$86.8 - $118.57 $258,664 - $353,338	2,980 New	2,980 $320,000

655

96.6M

282K

281K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.6B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbour Capital Advisors, LLC with notifications on news.